.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Emerging arboviral infections significantly threaten global transfusion systems. Consequently, healthcare providers must prioritize robust Arboviral blood safety measures to prevent the transmission of infectious agents. A recent international survey involving 21 countries evaluated how blood establishments manage these risks. The study analyzed data from nearly 30 million donations collected in 2024 to identify gaps in current safety protocols.
Researchers found that every respondent currently uses travel-based donor deferrals. However, this strategy alone may not remain sustainable during large-scale outbreaks. Extensive deferrals can drastically reduce the donor pool, leading to critical blood shortages. Furthermore, only half of the surveyed countries have implemented pathogen reduction technologies. These methods currently apply mostly to a selection of plasma and platelet donations rather than the entire supply.
Pathogen reduction technologies offer a universal safeguard by inactivating various viruses and bacteria. Despite their benefits, cost and logistical hurdles often impede their widespread adoption. West Nile virus (WNV) was the primary target for screening in the survey. While screening confirmed 256 WNV-positive donations, nine respondents noted that screening for other emerging viruses remains rare. Consequently, experts advocate for proactive risk assessments to determine if additional mitigation is necessary for viruses like Dengue, Chikungunya, and Zika.
In India, regulators are also enhancing safety standards. The Indian Pharmacopoeia 2026 now brings blood components under uniform standards to tighten oversight. This move, alongside the phased expansion of Nucleic Acid Testing (NAT), aligns with global efforts to modernize blood-safety architecture. Therefore, clinicians must stay updated on these evolving guidelines to ensure patient safety during transfusion therapy.
Donor deferral relies on identifying high-risk individuals, but large outbreaks can infect a significant portion of the population. This reduces the number of eligible donors. Consequently, relying solely on deferrals can cause severe blood supply shortages during epidemics.
Pathogen reduction technologies (PRTs) use chemical or light-based methods to inactivate pathogens within blood products. Unlike screening, which targets specific known viruses, PRTs provide a broad layer of protection against both known and emerging infectious agents.
No, current protocols are often limited. While many regions screen for West Nile Virus, screening for Dengue or Zika is not yet universal. Medical authorities recommend performing specific risk assessments to determine when additional screening or pathogen reduction is warranted.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
An international survey of 21 countries reveals that current arboviral blood safety measures are limited and unevenly distributed. While West Nile virus screening is established in some regions, growing threats from Dengue and Zika require urgent risk assessments and enhanced pathogen reduction strategies.
2 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
